MichaelDavidsonMD

Cardiology • Chicago, IL

Preventive Cardiology

Clinical Professor of Medicine, University of Chicago Medicine

Join to view full profile

Dr. Davidson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Davidson's full profile

Already have an account?

Office
5841 S Maryland Ave
Chicago, IL 60637
Phone+1 888-824-0200

Fax+1 773-834-7300

Education & Training

Rush University Medical CenterFellowship, Cardiovascular Disease, 1984 - 1986
Rush University Medical CenterResidency, Internal Medicine, 1981 - 1984
Ohio State University College of MedicineClass of 1981

Certifications & Licensure

IL State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

5 citations
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, d...
Christopher J Farina, Michael H Davidson, Prediman K Shah, Charles Stark, Wenqi Lu
Cardiovascular Research. 2024-05-29
1 citations
CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis.
Bohdan B Khomtchouk, Patrick Sun, Zane A Maggio, Marc Ditmarsch, John J P Kastelein
Frontiers in Endocrinology. 2024-01-01
3 citations
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).
Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj
Journal of the American Society of Nephrology. 2024-01-01

Lectures

The Power of Prevention: Lipid-Lowering Strategies for Cardiovascular Risk Reduction
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Lower TogetherLDL-C, Risk, Hassle, Cost
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
How to Build a Successful Lipid Clinic
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Press Mentions

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial HypercholesterolemiaDecember 10th, 2024
Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?August 15th, 2022
Uptake Uncertain for Potent New LDL-Lowerer InclisiranJanuary 26th, 2022
Join now to see all

Committees

member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015

Professional Memberships

American College of Cardiology - ACC
Member